Health Care Slips as Defensive Rotation Outweighs Pipeline Wins

EasyAlpha's data shows narrow participation across Health Care on Friday, September 18, with only 25.9% of its stocks posting gains. The sector's cap-weighted return of -0.2% held up better than the equal-weighted move of -0.5%, indicating that larger holdings buffered the broader weakness. The primary vehicle for the sector, an exchange-traded fund named the Health Care Select Sector SPDR Fund (XLV), closed -0.2% at $168.39. The move came as investors rotated out of defensive sectors amid broader shifts in market positioning.

Pipeline Advances and Single-Stock Drivers

Company developments presented a mixed picture across the sector:

• Eli Lilly received U.S. FDA approval for Inluriyo in combination with Verzenio for adults with advanced or metastatic breast cancer.
• Merck gained a positive European regulatory recommendation for a Keytruda combination in bladder cancer.
• AbbVie presented real-world observational data on Vraylar for depression treatment.

Despite positive regulatory updates, the broader group faced selling pressure, with Centene Corp (-3.0%) finishing as the sector's steepest decliner. Gains were led by The Cooper Companies, Inc (+2.8%) and Intuitive Surgical Inc (+2.6%). On a session where 3 of the 11 sectors rose, the sector remained constrained by broad rotation.

Sector Quality and Long-Term Performance

Across the sector's stocks, EasyAlpha places 53.3% of the fund's weight in A or B quality grades. Companies graded A or B have stronger fundamentals, and historically they have carried a lower risk of large drawdowns than companies graded D or E.

While XLV moved -4.1% over the past month, its longer-term trend remains positive. The fund has gained +17.1% over the past one hundred sessions, +15.9% over the past six months, and +22.5% over the past twelve months.